Lux Ventures Iv, L.p. - Net Worth and Insider Trading
Lux Ventures Iv, L.p. Net Worth
The estimated net worth of Lux Ventures Iv, L.p. is at least $132 Million dollars as of 2024-11-13. Lux Ventures Iv, L.p. is the 10% Owner of Recursion Pharmaceuticals Inc and owns about 17,387,095 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $132 Million. Details can be seen in Lux Ventures Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lux Ventures Iv, L.p. has not made any transactions after 2021-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lux Ventures Iv, L.p.
Lux Ventures Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lux Ventures Iv, L.p. owns 5 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Aeva Technologies Inc (AEVA) , and Science 37 Holdings Inc (SNCE) among others .
Click here to see the complete history of Lux Ventures Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Lux Ventures Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-12-07 | other: Former 10% Owner |
| AEVA | Aeva Technologies Inc | 2021-03-12 | 10 percent owner |
| SNCE | Science 37 Holdings Inc | 2021-10-06 | 10 percent owner |
 | | 2021-06-04 | 10 percent owner |
| | 2021-06-04 | 10 percent owner |
Lux Ventures Iv, L.p. Latest Holdings Summary
Lux Ventures Iv, L.p. currently owns a total of 1 stock. Lux Ventures Iv, L.p. owns 17,387,095 shares of Recursion Pharmaceuticals Inc (RXRX) as of April 16, 2021, with a value of $132 Million.
Latest Holdings of Lux Ventures Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-04-16 | 17,387,095 | 7.58 | 131,794,180 |
Holding Weightings of Lux Ventures Iv, L.p.
Lux Ventures Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Lux Ventures Iv, L.p. has made a total of 1 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the acquisition of 100,000 shares on April 16, 2021, which cost Lux Ventures Iv, L.p. around $2 Million.
Insider Trading History of Lux Ventures Iv, L.p.
- 1
Lux Ventures Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Lux Ventures Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lux Ventures Iv, L.p. is 5.5%. GuruFocus also compares Lux Ventures Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Lux Ventures Iv, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lux Ventures Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Lux Ventures Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -32.33 | | | | | |
| Relative Return to S&P 500(%) | -32.05 | | | | | |
Lux Ventures Iv, L.p. Ownership Network
Ownership Network List of Lux Ventures Iv, L.p.
Ownership Network Relation of Lux Ventures Iv, L.p.
Lux Ventures Iv, L.p. Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Lux Ventures Iv, L.p. is the other: Former 10% Owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include President and COO Tina Marriott Larson , Chief Financial Officer Michael Secora , and director & 10 percent owner & Chief Executive Officer Christopher Gibson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Lux Ventures Iv, L.p. made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 496,133 shares made by Blake Borgeson , a net sale of 1,209,278 shares made by Christopher Gibson , and a net sale of 94,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 256,682 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 256,682 shares. During the past 18 months, 2,974,541 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,974,541 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Lux Ventures Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Lux Ventures Iv, L.p.. You might contact Lux Ventures Iv, L.p. via mailing address: 295 Madison Avenue, 24th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
